FOXO (FOXO Technologies) ROE %: -55.70% (As of Mar. 2026)


What is FOXO Technologies ROE %?

FOXO Technologies FOXO -50.00% ROE % is -55.70% as of Mar. 2026. The stock has 5 warning signs investors should review. Among 628 Healthcare Providers & Services companies, FOXO Technologies ranks worse than 93.95% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. FOXO Technologies's annualized net income for the quarter that ended in Mar. 2026 was $-5.81 Mil. FOXO Technologies's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was $10.43 Mil. Therefore, FOXO Technologies's annualized ROE % for the quarter that ended in Mar. 2026 was -55.70%.

The historical rank and industry rank for FOXO Technologies's ROE % or its related term are showing as below:

FOXO' s ROE % Range Over the Past 10 Years
Min: -150.95   Med: -125.09   Max: -99.23
Current: -102.84

During the past 6 years, FOXO Technologies's highest ROE % was -99.23%. The lowest was -150.95%. And the median was -125.09%.

FOXO's ROE % is ranked worse than
93.95% of 628 companies
in the Healthcare Providers & Services industry
Industry Median: 5.72 vs FOXO: -102.84

FOXO Technologies  (OTCPK:FOXO) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-5.808/10.4265
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-5.808 / 20.672)*(20.672 / 45.182)*(45.182 / 10.4265)
=Net Margin %*Asset Turnover*Equity Multiplier
=-28.1 %*0.4575*4.3334
=ROA %*Equity Multiplier
=-12.86 %*4.3334
=-55.70 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=-5.808/10.4265
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-5.808 / -5.82) * (-5.82 / -1.108) * (-1.108 / 20.672) * (20.672 / 45.182) * (45.182 / 10.4265)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9979 * 5.2527 * -5.36 % * 0.4575 * 4.3334
=-55.70 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

FOXO Technologies ROE % Related Terms

FOXO Technologies ROE % Historical Data

* Premium members only.

The historical data trend for FOXO Technologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FOXO Technologies ROE % Chart

FOXO Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 -150.95

FOXO Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.78 -17.81 -44.22 -240.33 -55.70

FOXO vs WORX, MSPR, ESSID: ROE % Comparison

For the Health Information Services subindustry, FOXO Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FOXO Technologies ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, FOXO Technologies's ROE % distribution charts can be found below:

* The bar in red indicates where FOXO Technologies's ROE % falls into.


FOXO Technologies ROE % Calculation

FOXO Technologies's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-12.43/( (5.324+11.145)/ 2 )
=-12.43/8.2345
=-150.95 %

FOXO Technologies's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=-5.808/( (11.145+9.708)/ 2 )
=-5.808/10.4265
=-55.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of -55.70% mean?
FOXO Technologies (FOXO) has a ROE % of -55.70% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on FOXO Technologies and its competitors. According to the industry distribution chart, FOXO Technologies ranks #590 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 93.9%.
Is FOXO Technologies' ROE % too high?
FOXO Technologies' current ROE % is -55.70%. Based on the distribution chart, FOXO Technologies ranks #590 out of 628 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does FOXO Technologies' ROE % compare to WORX and MSPR?
According to the Healthcare Providers & Services industry distribution chart, FOXO Technologies ranks #590 out of 628 companies for ROE %. This places FOXO Technologies in the lower half of its industry. The industry median ROE % is 5.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on FOXO Technologies and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FOXO Technologies's current ROE % is -55.70%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
Based on GuruFocus' analysis, FOXO Technologies (FOXO) is currently considered Possible Value Trap. The stock's GF Value™ is $5.87, compared to a current price of $0.00 — trading 100% below its estimated fair value. The current ROE % is -55.70%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For FOXO Technologies (FOXO), the current ROE % is -55.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FOXO Technologies Business Description

Address 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.